Home Health Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents
HealthNews

Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents

389

On Monday, the World Health Organisation (WHO) announced its approval of Bavarian Nordic’s Jynneos vaccine for adolescents aged 12 to 17. This group is considered particularly vulnerable to mpox outbreaks. The vaccine was prequalified by the WHO on October 8, 2024, following its earlier approval for adults.

The approval comes after the European Union authorised the vaccine for adolescents in September. The WHO declared mpox a global public health emergency in August, after a new strain of the virus spread across many countries.

Bavarian Nordic is set to begin clinical trials to assess the vaccine’s safety for children aged two to 12. The trials are expected to start in October. Meanwhile, the U.S. FDA has approved the vaccine for adults.

Another mpox vaccine, LC16, developed by Japan’s KM Biologics, is already approved for use in children but requires a specialised needle for administration.

Read More:

About The Author

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

News

Tinubu Brings Shame to Japan: Shrine-Like Nigerian Booth With Undersized Display Exposes Empty Leadership

Nigeria’s delegation to the 9th Tokyo International Conference on African Development (TICAD9)...

NewsWorld

Senegal Condemns U.S. Sanctions on ICC Judges, Demands Withdrawal

The Government of Senegal has condemned the United States’ decision to impose...

NewsSports

Senegal Knocks Out Nigeria’s D’Tigers in AfroBasket Quarter-Final Clash

Nigeria’s hopes of reclaiming the AfroBasket title suffered a major blow on...

News

Putin Appoints Viktor Voropayev As Russian Ambassador To Niger, Embassy To Reopen After 33-Year Hiatus

Russian President Vladimir Putin has appointed Viktor Sergeyevich Voropayev as Ambassador Extraordinary...